Singapore markets closed
Straits Times Index
3,258.90 +1.72 (+0.05%) Nikkei
28,041.48 +258.55 (+0.93%) Hang Seng
20,400.11 +90.98 (+0.45%) FTSE 100
7,631.74 +11.31 (+0.15%) Bitcoin USD
28,368.21 -14.50 (-0.05%) CMC Crypto 200
621.79 +7.58 (+1.23%)
MedTech Acquisition Corporation (MTAC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 12:01PM EDT
| Previous close | 10.28 |
| Open | 10.20 |
| Bid | 10.23 x 800 |
| Ask | 0.00 x 1400 |
| Day's range | 10.20 - 10.27 |
| 52-week range | 9.78 - 10.68 |
| Volume | |
| Avg. volume | 816 |
| Market cap | 83.675M |
| Beta (5Y monthly) | -0.03 |
| PE ratio (TTM) | 53.68 |
| EPS (TTM) | 0.19 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business
DENVER & CHICAGO, February 21, 2023--TriSalus Life Sciences®, Inc. ("TriSalus" or the "Company"), an oncology company in the process of going public through a business combination transaction (the "Business Combination") with MedTech Acquisition Corporation (Nasdaq: MTAC) ("MedTech" or "MTAC"), today announced that James "Jim" Alecxih has joined the Company in the newly created role of President, Device Technology Business.
© 2023 Yahoo. All rights reserved.
